NO20073941L - Dihydroimidazotiazolderivater - Google Patents

Dihydroimidazotiazolderivater

Info

Publication number
NO20073941L
NO20073941L NO20073941A NO20073941A NO20073941L NO 20073941 L NO20073941 L NO 20073941L NO 20073941 A NO20073941 A NO 20073941A NO 20073941 A NO20073941 A NO 20073941A NO 20073941 L NO20073941 L NO 20073941L
Authority
NO
Norway
Prior art keywords
dihydroimidazotiazolderivater
reuptake inhibition
agonism
obesity
exhibit
Prior art date
Application number
NO20073941A
Other languages
English (en)
Inventor
Robert John Rowley
Gerard Hugh Thomas
Oscar Barba
Graham John Dawson
Thomas Martin Krulle
Donald Smyth
Original Assignee
Prosidion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prosidion Ltd filed Critical Prosidion Ltd
Publication of NO20073941L publication Critical patent/NO20073941L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Abstract

Forbindelser med formel (I):. eller farmasøytisk akseptable salter derav, oppviser 5-HT-agonisme i tillegg til noradrenalin-reopptaksinhibering, og eventuelt også 5-HT reopptaksinhibering, og er anvendelige for behandling av fedme.
NO20073941A 2005-02-08 2007-07-27 Dihydroimidazotiazolderivater NO20073941L (no)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US65090605P 2005-02-08 2005-02-08
US68436905P 2005-05-25 2005-05-25
US76166606P 2006-01-24 2006-01-24
PCT/GB2006/050031 WO2006085118A2 (en) 2005-02-08 2006-02-08 Dihydroimidazothiazole derivatives

Publications (1)

Publication Number Publication Date
NO20073941L true NO20073941L (no) 2007-11-05

Family

ID=36654712

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20073941A NO20073941L (no) 2005-02-08 2007-07-27 Dihydroimidazotiazolderivater

Country Status (16)

Country Link
US (1) US20090221645A1 (no)
EP (1) EP1851232A2 (no)
JP (1) JP2008530077A (no)
KR (1) KR20070107116A (no)
AR (1) AR053125A1 (no)
AU (1) AU2006212038A1 (no)
BR (1) BRPI0606881A2 (no)
CA (1) CA2597288A1 (no)
EA (1) EA012374B1 (no)
IL (1) IL184996A0 (no)
MA (1) MA29246B1 (no)
MX (1) MX2007009526A (no)
NO (1) NO20073941L (no)
NZ (1) NZ561006A (no)
TW (1) TW200639177A (no)
WO (1) WO2006085118A2 (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1923062A1 (en) 2006-11-16 2008-05-21 sanofi-aventis Imidazo[2,1-b]thiazoles and their use as pharmaceuticals
GB0916608D0 (en) 2009-09-22 2009-11-04 Angeletti P Ist Richerche Bio Therapeutic compounds
WO2012120054A1 (de) 2011-03-08 2012-09-13 Sanofi Di- und trisubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
US8710050B2 (en) 2011-03-08 2014-04-29 Sanofi Di and tri- substituted oxathiazine derivatives, method for the production, method for the production thereof, use thereof as medicine and drug containing said derivatives and use thereof
EP2683704B1 (de) 2011-03-08 2014-12-17 Sanofi Verzweigte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
WO2012120056A1 (de) 2011-03-08 2012-09-13 Sanofi Tetrasubstituierte oxathiazinderivate, verfahren zu deren herstellung, ihre verwendung als medikament sowie sie enthaltendes arzneimittel und deren verwendung
EP2766349B1 (de) 2011-03-08 2016-06-01 Sanofi Mit carbozyklen oder heterozyklen substituierte oxathiazinderivate, verfahren zu deren herstellung, diese verbindungen enthaltende arzneimittel und deren verwendung
EP2567959B1 (en) 2011-09-12 2014-04-16 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2016172692A1 (en) * 2015-04-24 2016-10-27 H. Lee Moffitt Cancer Center And Research Institute, Inc. Mutant kras inhibitors
EP4483875A3 (en) 2016-05-10 2025-04-02 C4 Therapeutics, Inc. Spirocyclic degronimers for target protein degradation

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1488314A (fr) * 1966-04-25 1967-07-13 Chimetron Sarl Imidazothiazolyl-benzimidazoles
CH507982A (de) * 1968-05-15 1971-05-31 Sandoz Ag Verfahren zur Herstellung von 2-Chloräthyl-3-phenyl-5, 6-dihydroimidazo(2,1-b)thiazolen bzw. -6,7-dihydro-5H-thiazolo(3,2-a)pyrimidinen
CH513918A (de) * 1968-07-31 1971-10-15 Sandoz Ag Verfahren zur Herstellung von 2-n-Alkyl-3-phenyl-6,7-dihydro-5H-thiazolo(3,2-a)pyrimidinen bzw. 2-n-Alkyl-3-phenyl-5,6-dihydroimidazo(2,1-b)thiazolen
US3671533A (en) * 1970-01-26 1972-06-20 Sandoz Ag 2,3,5,6-TETRAHYDROIMIDAZO{8 2,1-b{9 THIAZOLES
GB1556877A (en) * 1976-01-19 1979-11-28 Diamond Shamrock Corp Imidazothiazoles and thiazolopyrimidines
US4041167A (en) * 1976-01-19 1977-08-09 Diamond Shamrock Corporation Antiinflammatory imidazothiazoles
FR2643903A1 (fr) * 1989-03-03 1990-09-07 Union Pharma Scient Appl Nouveaux derives de benzimidazole, leurs procedes de preparation, intermediaires de synthese, compositions pharmaceutiques les contenant, utiles notamment pour le traitement des maladies cardiovasculaires, et des ulceres duodenaux

Also Published As

Publication number Publication date
TW200639177A (en) 2006-11-16
AR053125A1 (es) 2007-04-25
WO2006085118A2 (en) 2006-08-17
AU2006212038A1 (en) 2006-08-17
EA012374B1 (ru) 2009-10-30
KR20070107116A (ko) 2007-11-06
IL184996A0 (en) 2007-12-03
CA2597288A1 (en) 2006-08-17
EP1851232A2 (en) 2007-11-07
WO2006085118A3 (en) 2006-10-19
MA29246B1 (fr) 2008-02-01
BRPI0606881A2 (pt) 2009-07-21
NZ561006A (en) 2010-06-25
JP2008530077A (ja) 2008-08-07
EA200701676A1 (ru) 2008-02-28
US20090221645A1 (en) 2009-09-03
MX2007009526A (es) 2007-09-26

Similar Documents

Publication Publication Date Title
NO20080010L (no) GPCR-agonister
NO20082090L (no) Pyridopyrimidinoninhibitorer av P13K alfa
MX2009007180A (es) Agonistas del receptor acoplado a la proteina g de la piperidina.
NO20075082L (no) Pyridin-3-karboksamidderivater som CB1-inversagonister
NO20076066L (no) Oksadiazolderivater som DGAT-inhibitorer
NO20082096L (no) Azaindol-2-karboksamidderivativer
NO20076648L (no) Novel thiophene derivatives
NO20084418L (no) Azolopyridin-3-on derivater som inhibitorer av endoteliallipase
NO20084912L (no) Bisykliske derivater som CETP-inhibitorer
NO20081315L (no) Benzokinazolinderivater og deres anvendelse ved behandling av benlidelser
PT1940839E (pt) Inibidores de piridopirimidinona pi3k alfa
NO20090755L (no) Amino-imidazoloner og deres anvendelse som et medikament for behandling av kognitiv svekkelse, Alzheimers sykdom, neurodegenerering og demens
NO20071593L (no) Pyrimidinderivater
NO20082793L (no) Nye tiofenderivater
NO20062020L (no) 1-amino-2-oksysubstituerte tetrahydronaftalenderivater, fremgangsmate for fremstilling derav, og deres anvendelse som antiflogistika
NO20084307L (no) Heterocykliske GPCR agonister
ATE557024T1 (de) Piperidinverbindungen als gpcr-agonisten
NO20074275L (no) 2- (4-okso-4H-kinazolin-3-yl) acetamider og deres anvendelse som Vasopressin-V3-antagonister
MA32467B1 (fr) Derives de piperidinyle agonistes de gpcr
NO20064599L (no) Substituerte morfolin- og tiomorfolinderivater
DK1771178T3 (da) Anvendelse af K-252A og kinaseinhibitorer til forebyggelse eller behandling af HMGB1-assocuerede patologiske tilstande
NO20072963L (no) 5-substituerte kinolin- og isokinolinderivater, fremgangsmate for deres fremstilling og deres anvendelse som betennelseshemmere
ATE557023T1 (de) Piperidinylverbindungen als gpcr-agonisten
PL1891029T3 (pl) Związki organiczne do leczenia stanów zapalnych lub alergicznych
NO20080394L (no) N-(arylalkyl)-1H-pyrrolopyridin-2-karboksamidderivater, fremstilling og anvendelse derav

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application